Enbrel 50 mg solution for injection in pre-filled pen
Sponsors
Queen Mary University Of London, UZ Leuven, IRCCS Istituto Giannina Gaslini
Conditions
Juvenile idiopathic arthritisRheumatoid Arthritis
Phase 4
The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
RecruitingCTIS2022-502021-18-00
Start: 2023-10-12Target: 182Updated: 2026-01-19
RCT part:
CareRA2020: Effectiveness of a combination of Methotrexate and a step down glucocorticoid regimen (COBRA-Slim) for remission induction in patients with early Rheumatoid Arthritis (RA), with or without fast access to 24 weeks of Tumor Necrosis Factor (TNF) blockade in insufficient responders, a randomized, multicenter, pragmatic trial.
LTE part:
CareRA2020 LTE: a 3 year longitudinal observational, multicenter, follow-up of early RA patients after participation in the CareRA2020 RCT.
CompletedCTIS2023-510189-28-00
Start: 2018-05-15End: 2025-07-08Target: 442Updated: 2024-02-01
Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized clinical trial comparing early versus late drug withdrawal combining imaging and multi-Omics.
RecruitingCTIS2024-514732-24-00
Start: 2025-04-28Target: 328Updated: 2025-08-26